ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane
- 1 June 1976
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 3 (2), 95-107
- https://doi.org/10.1016/s0305-7372(76)80007-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The bioavailability in man of ICRF-159 a new oral antineoplastic agentJournal of Pharmacy and Pharmacology, 1975
- The effect of (±) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphomaEuropean Journal of Cancer (1965), 1975
- Prenatal effects of the cancer chemotherapeutic drug ICRF 159 in mice, rats, and rabbitsTeratology, 1975
- Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159British Journal of Cancer, 1974
- ICRF 159The Lancet, 1974
- Cumulative Cytostatic Effect of ICRF 159Nature, 1974
- Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic TissueBritish Journal of Haematology, 1972
- ANTI-METASTATIC EFFECT OF ASPIRINThe Lancet, 1972
- Control of Malignant Metastases by ICRF 159Nature, 1969
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969